Business Wire

Agendia Appoints Suja Chandrasekaran and Scott Mendel to Board of Directors, Strengthening Advisory Group to Support Company Momentum

Share

Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS and Scott Mendel, MBA to the Company’s Board of Directors.

“We are pleased to be expanding Agendia’s Board of Directors with the appointment of two accomplished industry executives,” said Mark Straley, Chief Executive Officer of Agendia. “With combined decades of leadership and results-driven performance, Suja and Scott will provide Agendia with invaluable guidance, informed by extensive executive experience. As we continue to deliver on our goal to provide crucial genomic information to physicians and their patients to improve care, we look forward to tapping into their diverse expertise.”

“Suja’s reputation for growing, scaling, and transforming global businesses with data-driven go-to-market strategies and business vision is unparalleled,” said Patrick J. Balthrop, Chairman of the Board at Agendia. “Similarly, Scott’s executive insights and deep financial experience will be integral assets as we position the business for ongoing operational excellence and commercialization to best serve the breast cancer community.”

Suja Chandrasekaran, MS

Ms. Chandrasekaran joins Agendia’s Board with over 25 years of experience in building businesses in retail, consumer, manufacturing, and healthcare. Her specialties include risk management, ESG, and the employment of digital capabilities to drive growth and revenue. Ms. Chandrasekaran currently serves as Senior Executive Vice President, Chief Digital and Information Officer at CommonSpirit Health, where she leads the digitization of healthcare focusing on unleashing the power of data with AI to provide rich patient and provider experiences. Previously she was the Global Chief Technology Officer at Walmart Inc. and Kimberly-Clark Corporation. She also serves on the boards of American Eagle Outfitters and Blume Global Technologies.

Ms. Chandrasekaran earned her Master of Business Systems at Monash University in Melbourne, Australia and her Bachelors in Electrical Engineering from the University of Madras, India. She holds many prestigious honors recognizing her technology and digital leadership, including her recent induction into the CIO Hall of Fame.

“Agendia is harnessing impressive science to deliver state-of-the-art solutions to the breast cancer community and I’m honored to contribute to the company’s meaningful mission,” said Chandrasekaran. “I am especially excited by the technology supporting MammaPrint and BluePrint genomic tests as well as the potential future expansion into next generation sequencing and digital AI pathology solutions to follow the patient throughout her journey.”

Scott Mendel, MBA

Mr. Mendel is an industry veteran with over 25 years in public and private corporate leadership, notably in healthcare, software, and diagnostics. Most recently, Mr. Mendel served as the Chief Executive Officer of GenMark Diagnostics, overseeing a period of rapid growth and the process that ultimately led to the company’s purchase by Roche Diagnostics. Mr. Mendel previously served as GenMark’s Chief Operating Officer and Chief Financial Officer, leveraging his deep expertise in finance and manufacturing scale-up, fund raising and investor relations, and general commercial operations and strategy.

Prior to GenMark, Mr. Mendel held senior-level leadership positions with The Active Network and GE Healthcare. He serves as Audit Committee Chair and Compensation Committee member at Akoya Biosciences and is a member of Board of Advisors at Specific Diagnostics and Visby Medical. He holds a Bachelor of Science in finance from Indiana University and a Master of Business Administration from Northwestern University’s Kellogg School of Management.

“I am thrilled to join Agendia’s Board of Directors and to partner with the impressive, mission-driven genomic specialists, operational talent, and industry leaders in our shared vision,” said Mendel. “I look forward to contributing my executive expertise as Agendia pursues its objectives to advance genomic testing in breast cancer and improve outcomes for patients.”

The Agendia Board and management team is committed to bringing in and utilizing strong executive and operational talent at all levels to align with the superior execution and focus on propelling the Company’s advancement in all areas. We believe this dedication translates into exceptional science, actionable and transformative research, and bringing innovative new products to market to ensure breast cancer patients, their families and their physicians have access to the information they need to make the best decisions about the treatment journey. Learn more here.

About Agendia

Agendia is a mission-driven company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve outcomes for breast cancer patients worldwide. The company currently offers two commercially-available genomic profiling tests that help surgeons, oncologists and pathologists to personalize treatment for women at critical intervention points throughout their patient journey.

MammaPrint® is a 70-gene prognostic test that, along with other clinicopathologic factors, determines a specific patient’s breast cancer recurrence risk. BluePrint® is an 80-gene molecular subtyping test that identifies the underlying biology of an individual breast cancer to provide information about its behavior, long-term prognosis and potential response to systemic therapy. Together, MammaPrint® and BluePrint® provide a holistic view of an individual patient’s breast cancer, enabling physicians to objectively select the best treatment plan.

For more information on Agendia’s assays and ongoing trials, please visit www.agendia.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media:

Terri Clevenger
Westwicke/ICR Healthcare PR
Tel: 203.856.4326
Terri.Clevenger@icrinc.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Faster Air Quality Mapping Thanks to Ricardo’s RapidAir Software18.1.2022 03:01:00 EET | Press release

RapidAir®, developed by the global air quality, energy and environment specialists, is the next generation dispersion modelling and policy support platform that enables users to test the impact of scenarios in minutes, supporting the identification of measures that will reduce traffic emissions and consequently improve public health. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220117005253/en/ RapidAir air quality software (Photo: Business Wire) The ground-breaking air quality dispersion modelling software has already been successfully used across Asia, Europe and the UK, supporting Clean Air Zone evaluations, traffic management measures and wider air quality management activities. In response to requests from clients, including transport and health professionals, Ricardo has developed a cloud-based RapidAir software, complimenting its consultancy offering and making the capabilities of RapidAir more accessible to profess

Megaport Announces Partnership with TD SYNNEX as Leading Network as a Service (NaaS) Vendor Partner18.1.2022 00:00:00 EET | Press release

Megaport Limited (ASX: MP1) ("Megaport"), a global leading Network as a Service (NaaS) provider, today announces a partnership with TD SYNNEX, a global IT distributor and solutions aggregator, to make Megaport’s global, private Software Defined Network (SDN) platform available to TD SYNNEX customers. “Bringing Megaport’s leading Network as a Service platform into the TD SYNNEX portfolio makes it easier for customers to modernize their network connectivity and connect quickly to leading cloud service providers,” said Rodney Foreman, Chief Revenue Officer at Megaport. “TD SYNNEX’s global scale and reach, combined with their expertise in IT solutions, makes them an ideal partner to expand our channel relationships.” "TD SYNNEX is committed to delivering IT solutions to our customers that unlock their growth," said Cheryl Neal, vice president of New Vendor Acquisition, TD SYNNEX. "Adding Megaport’s Network as a Service offerings to our vast portfolio of IT solutions enables our customers t

Tech Mahindra Bets Big on Digitally Transforming Insurance Industry; Acquires Com Tec Co IT Ltd and Invests in Two Leading InsurTech Platforms17.1.2022 17:52:00 EET | Press release

Tech Mahindra, a leading provider of digital transformation, consulting, and business re-engineering services & solutions, today announced 100% acquisition of Com Tec Co IT Ltd (CTC) for €310 million including earnouts and synergy linked payouts. CTC is an IT solutions and service provider serving the insurance and financial services industries with development centres in Latvia and Belarus. The acquisition will enable Tech Mahindra to tap onto the potential industry disruption in the Insurance sector, expand its offerings to high-end digital engineering services for some of the largest insurance, reinsurance and financial services organizations globally and scale its nearshore delivery presence. Tech Mahindra is also investing a cumulative amount of €20 million, in SWFT and Surance, for a 25% ownership in each of these two InsurTech ventures funded by the same founding group as CTC. SWFT is a SaaS-based digital customer engagement platform. It offers multiple functionalities for insur

Toshiba Appoints Andrew McDaniel to Lead Its European Retail Business17.1.2022 16:00:00 EET | Press release

Toshiba Global Commerce Solutions today announced the appointment of technology and business innovator Andrew McDaniel as managing director and senior vice president of Europe effective January 15, 2022. Based in Ireland, McDaniel will assume leadership of all European operations, reporting to Rance Poehler, global president and CEO, Toshiba Global Commerce Solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220117005027/en/ Andrew McDaniel, Managing Director and Senior Vice President of Europe, Toshiba Global Commerce Solutions (Photo: Business Wire) “Europe is a dynamic market at the forefront of retail innovation, and home to many of our customers and partners,” said Poehler. “With our commitment to retail growth globally, Andrew, with his proven track-record and deep experience in technology solution development and business innovation, is exactly the right person to lead our drive to accelerate digital transformat

Stallergenes Greer Strengthens Precision Medicine Approach in Allergen Immunotherapy With Imperial College London Research Collaboration17.1.2022 14:37:00 EET | Press release

Stallergenes Greer, a global healthcare company specialising in allergen immunotherapy (AIT), today announced that the company has entered into a research collaboration on the discovery of biomarkers of AIT efficacy with Imperial College London, a global top ten university with a world-class reputation in science, engineering, business and medicine. This long-term research collaboration, which combines the long-standing expertise of Stallergenes Greer in AIT with the prestigious research capabilities of Imperial College London, aims to push the boundaries of allergic patient care by identifying biomarkers of AIT efficacy and expanding the knowledge of the pathophysiology of allergic diseases and their treatment with AIT. “We are thrilled about this collaboration with Imperial College London which will contribute to both deciphering the mode of action of AIT and identifying key markers that can be used in the routine practice of allergology for the benefit of patients and healthcare pra

Elliptic Launches Market Intelligence Unit and Announces New Proposition for Crypto Traders17.1.2022 14:10:00 EET | Press release

Elliptic, the leading provider of on-chain blockchain analytics, today announces the launch of its market intelligence unit; a second line of business for the organization that is focused on leveraging Elliptic’s best-in-class identity graph to build new propositions and use cases for businesses trading crypto. The new unit, led by Elliptic co-founder James Smith and Laura Coffey, will harness Elliptic’s dataset as an intrinsically valuable data layer for the burgeoning institutional crypto trading market. The data will provide access to the broadest asset coverage of on-chain identity metrics in the industry, allowing traders to: Forecast: Utilize real insights behind the movements of money to access fundamental activity metrics for a wide range of cryptoassets React: Profile the different types of actors behind deposits, withdrawals and other transactions in real-time to assess the motivations behind market-moving activity Analyze: Explore flows between businesses and other types of

38% of Supplier Survey Respondents Use Early Payment to Manage Working Capital, Up From 19% In 201717.1.2022 13:00:00 EET | Press release

38% of respondents take early payments monthly in 2021, up from 19% in 2017, according to a supplier sentiment survey conducted by Taulia, the leader in working capital technology solutions. Taulia’s global supplier sentiment survey has been conducted annually since 2017 and reflects the views of nearly 80,000 respondents over a five-year period. There has been growing interest from suppliers in regularly receiving early payment once an invoice is approved as an alternative source of finance. In 2021, one-fifth (22%) of suppliers were interested in receiving early payment every time for every customer, compared to 15% in 2017. The supplier's reasons for taking early payments varied. In 2021, the main reasons for their interest in early payments were*: Cash flow gap (49%) Collections/payment predictability (27%) Working capital needs (21%) Ease of use (18%) Reduce DSO (7%) There is also a clear progression towards better behaviour from businesses with a welcome decrease in late payment,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom